An Exploratory Factor Analysis of Pharmacists' Drug Product Recommendations to Physicians for Panic Disorder Patients

References

• Weissman MM. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl I Med 1989;32:1209–14.
   Google Scholar
• Wood WG. The diagnosis and management of panic disorder. Psychiatr Med 1990;8:197–209.
   Google Scholar
• Schroeder SA, et at., eds. Current medical diagnosis and treatment. Nor-walk, Cr: Appleton and Lange, 1992.
   Google Scholar
• Baiter MB, Levine 3. The nature and extent of psychotherapeutic drug usage in the United States. Psychopharmacol Bull 1969;5: 3.
   Google Scholar
• Beardsley RS, et at. Prescribing of psychotropic medication by primary care physicians and psychiatrists. Arch Gen Psychiatry 1988;45:1117–9.
   PubMed Web of Science ®Google Scholar
• Sheehan DV. Current perspectives in the treatment of panic and phobic dis-orders. Drug Thor 1982;179–90.
   Google Scholar
• Scringnar CB. Postpanic anxiety disorder: diagnosis and treatment. South Med I 1.986;79:4130-4.
   Google Scholar
• Ballenger IC. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. Arch Gen Psychiatry 1988;45:413–21.
   PubMedGoogle Scholar
• Reich P. Panic attacks and the risk of suicide. N Engl J. Med 1989;321:1260–1.
   Google Scholar
• Edlund M. The economic and social costs of panic disorder. Hasp Form 1991;26:28–31.
   PubMedGoogle Scholar
• Danner DL Effect of alprazolam, and diazepam on anxiety and panic at-tacks in panic disorder: a controlled study. I Clin Psychiatry 086;47:458–60.
   Google Scholar
• Noyes R. Alprazolam in panic disorder and agoraphobia: results front a multicenter trial. Part II. Arch Gen Psychiatry 1988;45:423–8.
   PubMed Web of Science ®Google Scholar
• Uhlenhuth EH. Risks and benefits of long-term benzodiazepine use. J Clin Psychoptiannacol 1988;8:161–7.
   PubMed Web of Science ®Google Scholar
• Taylor CB. Cardiovascular and symptomatic reduction effects of alprazo-lam and ilnipramine in patients with panic disorder: results of a double-blind, pla-cebo-controlled irial..I Clin Psychopharrnacol 1990;10:112–8.
   Google Scholar
• Lydiard P.B. Recent advances in the psychopharmacological treatment of anxiety disorders. Hoop Community Psychiatry 1988;39:1157–65.
   PubMedGoogle Scholar
• Miller RR. Prescribing habits of physicians: PartsDrug Intell ClinPharm 1973;7:492–564.
   Google Scholar
• Benson PR. Factors associated with antipsychotic drug prescribing by Southern psychiatrists. Med Care 1983;20:639–54.
   Google Scholar
• Staudenmayer H, Leflcowitz MS. Physician-patient psychosocial charac-teristics influencing medical decision-making. Soc Sci Med 1981;15E:77–81.
   Google Scholar
• Hadsall RS, Freeman RA, Norwood GI. Factors related to the prescribing of selected psychotropic drugs by primary care physicians. Soc Sci Med 1982.16:1747–56.
   Google Scholar
• Worthen DB. Prescribing influences: an overview. Br I Med Educ 1973;7:109.
   Google Scholar
• Williams JR, Hensel Pl. Changes in physicians' sources of pharmaceutical infonnation: a review and analysis. J Health Care Market 1991;3(Sept):46–60.
   Google Scholar
• Caplow T, Raymond D. Factors influencing the selection of pharmaceuti-cal products. I Market 1954;19(1):18–23.
   Google Scholar
• Hemminki B. Review of literature on the prescribing factors affecting drug prescribing. Soc Sci Med 1975;9:11–6.
   Web of Science ®Google Scholar
• Lifla I. How physicians choose their drugs. Soc Sci Med 1976;10:363–5.
   Google Scholar
• Harrell GD, Bennett PD. An evaluation of the expectancy value model of attitude measurement for physician prescribing behavior. J Market Res 1974; 11:269–78.
   Web of Science ®Google Scholar
• Green PE, Krieger AM. Segmenting mantels with conjoint analysis. J Mar-ket 1991;55(0c0:20–31.
   Google Scholar
• Juergens JP, Banahan BF, Partridge IA. Pharmacists' impact on medical therapy decisions. Pharm Times 1989;55(9):43+.
   Google Scholar
• Summers 8I4, Gumbhir AK.. The expected impact of managed health care organizations on the research-intensive U.S. pharmaceutical industry. J Phann Market Manage 1991;5(3):65–77.
   Google Scholar
• Denig P, Ruskamp FM, Zijsling DH. How physicians choose drugs. Sec Sci Med 1988;27:1381–6.
   PubMed Web of Science ®Google Scholar
• Knapp DE, Oeltjen PD. Benefits-to-risks ratio in physician drug selection. J Public Health 1972;62:1346–7.
   Google Scholar
• Zelnio RN. The interaction among the criteria physicians use when pre-scribing. Med Care 1982;10:277–85.
   Google Scholar
• Churchill GA Jr. A paradigm for developing better measures of marketing constructs. J Market Res 1979;16:64–73.
   Google Scholar
• Gorsuch teL Factor analysis. Hillsdale, NJ: Lawrence Erlbaum, 1983.
   Google Scholar
• Armstrong IS, Overton TS. Estimating nonresponse bias in mail surveys. J Market Res 1977;14:396–402.
   Web of Science ®Google Scholar
• Cronbach LT. Coefficient alpha and internal structure of tests. Psychome-trika 1951;16:297–334.
   Web of Science ®Google Scholar
• Normally SC. Psychometric theory. New York: McGraw-Hill Book Com-pany, 1978.
   Google Scholar
• Harman RH. Modem factor analysis. 3rd ed. Chicago: University of Chi-cago Press, 1976.
   Google Scholar
• Hair IF Jr, Anderson RE, Tatham. RL. Multivariate data analysis. 2nd ed. New York: Macmillan Publishing Company, 1987.
   Google Scholar
• Kaiser HE The application of electronic computers to factor analysis. Educ Psychol Measure 1960;20:141–51.
   Google Scholar
• Stevens J. Applied multivariate statistics for the social sciences. Hillsdale, NJ: Lawrence Erlbaum, 1986.
   Google Scholar
• Parasuraman A, Zeithaml VA, Berry LL. SERVQUAL: a multiple-item scale for measuring consumer perceptions of service quality. J Retail 1988;64(0:12–413.
   Google Scholar
• Hepler CD. Future of pharmacy: pharmaceutical care. Am Pharrn 1990;NS30:23–39.
   Google Scholar
• Szeinbach SL, Freeman JK, Barnes 114, Summers ICH. Modeling physi-cians' prescribing decisions for patients with panic disorder. Unpublished.
   Google Scholar